BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) Stock Information | RedChip

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)


$7.4650
+0.0750 ( +2.97% ) 944.5K

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Market Data


Open


$7.4650

Previous close


$7.3900

Volume


944.5K

Market cap


$1.55B

Day range


$7.2500 - $7.4890

52 week range


$4.0300 - $8.8800

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Sep 30, 2024
4 Insider transactions 1 Sep 03, 2024
10-q Quarterly Reports 84 Aug 06, 2024
8-k 8K-related 15 Aug 05, 2024
4 Insider transactions 1 Jun 25, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024

Latest News